Europe Flow Cytometry Market
시장 규모 (USD 10억)
연평균 성장률 :
% 
 예측 기간 |
2023 –2030 |
 시장 규모(기준 연도) |
USD 1,265.49 Million |
 시장 규모(예측 연도) |
USD 2,563.23 Million |
 연평균 성장률 |
% |
| 주요 시장 플레이어 |
|
>유럽 유세포 분석 시장, 제품별(유세포 분석 기기, 시약 및 소모품, 소프트웨어, 액세서리 및 서비스), 기술(세포 기반 유세포 분석 및 비드 기반 유세포 분석), 응용 분야(연구 응용 분야, 임상 응용 분야 및 산업 응용 분야), 최종 사용자(학계 및 연구 기관, 병원, 제약 및 생명 공학 회사, 임상 시험 실험실, 혈액 은행 및 기타), 유통 채널(직접 입찰 및 소매 판매) - 업계 동향 및 2030년까지의 예측.
유럽 유세포 분석 시장 분석 및 통찰력
유럽 흐름 세포 분석 시장은 만성 질환의 유병률 증가, 흐름 세포 분석 시장에서 새로운 기술에 대한 수요 증가(수요 증가), 연구 개발에 대한 투자 증가(시장 성장으로 이어짐)와 같은 요인에 의해 주도됩니다. 현재 선진국과 신흥국에서 의료비 지출이 증가하여 제조업체가 새롭고 혁신적인 흐름 세포 분석 시장을 개발할 수 있는 경쟁 우위를 확보할 것으로 예상됩니다. 그러나 흐름 세포 분석 장비의 높은 비용이 유럽 흐름 세포 분석 시장 성장을 제한할 것으로 예상됩니다.
유럽 유세포 분석 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 새로운 수익 창출, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 분석 기회에 대한 세부 정보를 제공합니다. 분석 및 시장 시나리오를 이해하려면 분석가 브리핑을 위해 당사에 문의하세요. 당사 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드립니다. 다양한 지역의 개발도상국에 있는 소매점의 확장성과 사업 확장, 기계 및 의약품의 안전한 유통을 위한 공급업체와의 파트너십은 예측 기간 동안 시장 수요를 촉진한 주요 원동력입니다.
유럽 유세포 분석 시장은 2023년부터 2030년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2023년부터 2030년까지의 예측 기간 동안 9.3%의 CAGR로 성장하고 있으며 2022년 1,265.49백만 달러에서 2030년까지 2,563.23백만 달러에 도달할 것으로 예상된다고 분석합니다.
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2023년부터 2030년까지 |
|
기준 연도 |
2022 |
|
역사적 연도 |
2021 (2015-2020까지 사용자 정의 가능) |
|
양적 단위 |
수익 (단위: USD 백만) |
|
다루는 세그먼트 |
By Product (Flow Cytometry Instruments, Reagents and Consumables, Software, Accessories, and Services), Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Academic & Research Institutes, Hospitals, Pharmaceutical & Biotechnology Companies, Clinical Testing Laboratories, Blood Bank, and Others), Distribution Channel (Direct Tenders, and Retail Sales) |
|
Countries Covered |
Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Belgium, Rest of Europe |
|
Market Players Covered |
Thermo Fisher Scientific Inc. (U.S.), BD(U.S.), Agilent Technologies, Inc. (U.S.), Sartorius AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Sysmex Corporation(Japan), Coherent Corp. (U.S.), Beckman Coulter, Inc. (A subsidiary of Danaher Corporation) (U.S.), BIOMÉRIEUX (France), Merck KGaA (Germany), Sony Biotechnology Inc. (U.S.), Apogee Flow Systems Ltd. (U.K.), Bay bioscience Co., Ltd.(Japan), NeoGenomics Laboratories(U.S.), Enzo Biochem Inc. (U.S.), ORLFO Technologies, CytoBuoy b.v., Elabscience Biotechnology Inc., Takara Bio Inc. (U.S.), Union Biometrica, Inc. (U.S.), Nexcelom Bioscience LLC(U.S.), among others |
Market Definition
Flow cytometry is a key process for screening cells from a heterologous cell mixture used in cell sorting, counting, protein regeneration, and engineering. The analysis of cell surface and intracellular molecule expression, the characterization and definition of various cell types in a heterogeneous cell population, the evaluation of the purity of isolated subpopulations, and the measurement of cell size and volume are all common uses for flow cytometry. It enables the simultaneous examination of multiple parameters for a single cell. A flow cytometer uses lasers to produce light, which is subsequently dispersed by the sample's cells, recorded by detectors, and converted into signals for analysis and measurement.
The increasing innovations and technologies, and rising number of players in the market, and novel product launches are also propelling the growth of the Europe flow cytometry market.
Europe Flow Cytometry Market Dynamics
Drivers
- Rising prevalence of chronic diseases
These increasing prevalence and incidences of chronic diseases are likely to drive market growth by focusing on cytometry devices. The increasing incidences of diseases lead to an increase in the Europe market as many companies are investing in research and development. This resulted in the enormous lead in demand for advancements to diagnose the disease through quick and accurate techniques.
For instance,
- In January 2021, according to a World Health Organization report, cancer became the major cause of death in 2020, with 10 million in approximation, where often cases were of breast cancer (2.26 million), lung (2.21 million), colon and rectum (1.93 million); prostate (1.41 million), skin (1.20 million) and stomach (1.09 million)
Therefore, this is raising the demand for the flow cytometry market.
- Increasing application of cytometry instruments
Technological developments in cytometry instruments are rising by combining several new techniques to provide high resolution and sensitivity to quantify new entities of cells.
The immunophenotypic analysis is important not only for the initial diagnosis and categorization of acute leukemia, chronic lymphoproliferative disorders, and malignant lymphomas but also for their treatment. Flow cytometry can be used as a sensitive assay to track patients' improvement after chemotherapy or transplantation and detect minimal residual illness (MRD).
For instance,
- In January 2022, Becton, Dickinson and Company, a Europe medical technology company, announced that a study conducted in collaboration with the European Molecular Biology Laboratory (EMBL) and published the new BD innovation in flow cytometry that adds fluorescence imaging and image-based deaccessioning to sort individual cells at exceptionally high speed, based on the visual details of each cell rather than the type or quantity of biomarkers present. The novel method has the potential to revolutionize immunology, cell biology, and genomics research, as well as enable the development of new cell-based therapeutics
Thus, this is expected to act as a driver for the growth of the flow cytometry market.
Opportunities
- Growth in stem cell research and acquisition of recombination of DNA technologies
The growth in stem cell research includes factors that rapidly increase cell proliferation or differentiations where laser-based cytometry can be utilized for the analysis of characteristics of stem cells.
The flow cytometry assesses this phase and detects the cell distribution within to calculate the frequency of apoptotic cells with fractional DNA content.
For instance,
- A well-known company Thermo Fisher Scientific Inc., on the production line, has Alexa Fluor 488 Flow Cytometry Assay Kit for the detection of DNA replication and proliferation of cells
Thus, these opportunities are expected to boost the demand for flow cytometry in the region.
- Increase in adoption of flow cytometry techniques in research and academia
Flow cytometry is a sophisticated technique for measuring individual cells and other particles in suspension at a rate of thousands of cells per second. Flow cytometry has been extended to environmental investigations, extracellular vesicle analysis, and the capacity to use upwards of 30 different parameters for more extensive analysis. It is most typically used in the setting of immunology.
For instance,
- In December 2018, the News-Medical.net article stated that combining fluorescent-tagged monoclonal antibodies with flow cytometry is commonly used among cancer researchers. Similarly, after over a decade of extensive research, high-throughput image-based flow cytometry is now accepted and widely used in scientific research and academics, particularly in cancer biology
Restraints/Challenges
- High cost of flow cytometry instruments
Flow cytometers come in a variety of shapes and sizes, although benchtop instruments are the most common. They offer optimal data analysis, the convenience of use, and upgrades and options for various systems, all of which are intended to solve customized separations, cell/particle sorting, exploratory cell analysis, and other issues. All flow cytometers feature three common components – fluids, optics, and electronics/informatics.
Flow cytometers are very expensive especially considering the cost associated with repair and maintenance.
COVID-19 Impact on the Europe Flow Cytometry Market
COVID-19 has positively affected the market due to disease diagnosis and research purposes, which raises the demand for flow cytometry during this period.
Recent Development
- In January 2022, Sony Biotechnology, Inc. presented a novel closed cell isolation system CGX10 for use in GMP-compliant cell sorting applications. With the initiative, new growth opportunities were hoped for the company. Such advances in technology will lead to cost-effectiveness, greater accuracy and portability and are likely to create future growth opportunities.
Europe Flow Cytometry Market Scope
The Europe flow cytometry market is segmented into product, technology, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Product
- Reagents and consumables
- Flow cytometry instruments
- Accessories
- Services
- Software
On the basis of product, the Europe flow cytometry market is segmented into flow cytometry instruments, reagents and consumables, software, accessories, and services.
Technology
- Cell-based flow cytometry
- Bead-based flow cytometry
On the basis of technology, the Europe flow cytometry market is segmented into cell-based flow cytometry and bead-based flow cytometry.
Application
- Research applications
- Clinical applications
- Industrial applications
On the basis of application, the Europe flow cytometry market is segmented into research applications, clinical applications, and industrial applications.
End User
- Pharmaceuticals & biotechnology companies
- Academic & research institutes
- Hospitals
- Clinical testing laboratories
- Blood Bank
- Others
On the basis of end users, the Europe flow cytometry market is segmented into academic & research institutes, hospitals, pharmaceutical & biotechnology companies, clinical testing laboratories, blood bank, and others.
Distribution Channel
- Retail sales
- Direct tenders
On the basis of the distribution channel, the Europe flow cytometry market is segmented into retail sales and direct tenders.
Europe Flow Cytometry Market Regional Analysis/Insights
위에 언급된 대로 유럽 유세포분석 시장을 분석하고, 국가, 유형, 기술 및 최종 사용자별로 시장 규모에 대한 통찰력과 추세를 제공합니다.
독일은 임상 시험이 많이 진행되고 건강 문제에 대한 인식이 높아지면서 유럽 유세포 분석 시장을 지배할 것으로 예상됩니다. 그들은 시장 점유율과 시장 수익 측면에서 유세포 분석 시장을 지배하고 있으며 예측 기간 동안 지배력을 계속 확대할 것입니다.
보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규정의 변화를 제공합니다. 신규 및 교체 판매, 국가 인구 통계, 질병 역학 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 유럽 브랜드의 존재 및 가용성과 국내 및 국내 브랜드와의 치열한 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
경쟁 환경 및 유럽 유세포 분석 시장 점유율 분석
유럽 유세포 분석 시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 유럽 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 위에 제공된 데이터 포인트는 유럽 유세포 분석 시장에 대한 회사의 초점과만 관련이 있습니다.
유럽 유세포 분석 시장의 주요 기업으로는 Thermo Fisher Scientific Inc., BD, Agilent Technologies, Inc., Sartorius AG, Bio-Rad Laboratories, Inc., Sysmex Corporation, Coherent Corp., Beckman Coulter, Inc. (Danaher Corporation의 자회사), bioMérieux SA, Merck KGaA, Sony Biotechnology Inc., Apogee Flow Systems Ltd., Bay bioscience Co., Ltd., NeoGenomics Laboratories, Enzo Biochem Inc., ORLFO Technologies, CytoBuoy bv, Elabscience Biotechnology Inc., Takara Bio Inc., Union Biometrica, Inc., Nexcelom Bioscience LLC 등이 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE FLOW CYTOMETRY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT SEGMENT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISING PREVALENCE OF CHRONIC DISEASES
5.1.2 INCREASING APPLICATION OF CYTOMETRY INSTRUMENTS
5.1.3 INCREASE IN USE OF FLOW CYTOMETRY IN DRUG DISCOVERY
5.1.4 GROWTH IN STEM CELL RESEARCH AND ACQUISITION OF RECOMBINATION OF DNA TECHNOLOGIES
5.2 RESTRAINTS
5.2.1 HIGH COST OF FLOW CYTOMETRY INSTRUMENTS
5.2.2 LIMITATIONS OF FLOW CYTOMETRY
5.2.3 LACK OF SKILLED PROFESSIONALS
5.3 OPPORTUNITIES
5.3.1 INCREASE IN ADOPTION OF FLOW CYTOMETRY TECHNIQUES IN RESEARCH AND ACADEMIA
5.3.2 DEVELOPMENT IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES
5.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
5.3.4 DEVELOPING A PIPELINE OF STEM CELL RESEARCH
5.4 CHALLENGES
5.4.1 DIFFICULTY IN THE DEVELOPMENT AND VALIDATION OF FLOW CYTOMETRY ASSAYS
5.4.2 COMPLEXITIES RELATED TO REAGENT DEVELOPMENT
6 EUROPE FLOW CYTOMETRY MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 REAGENTS AND CONSUMABLES
6.2.1 DYE
6.2.2 ANTIBODIES
6.2.3 BEADS
6.2.4 OTHERS
6.3 FLOW CYTOMETRY INSTRUMENTS
6.3.1 CELL ANALYZERS
6.3.1.1 CELL ANALYZERS, BY TYPE
6.3.1.1.1 IMAGING FLOW CYTOMETERS
6.3.1.1.2 NON-IMAGING FLOW CYTOMETERS
6.3.1.2 CELL ANALYZERS, BY MODALITY
6.3.1.2.1 BENCHTOP
6.3.1.2.2 STANDALONE
6.3.2 CELL SORTERS
6.3.2.1 BENCHTOP
6.3.2.2 STANDALONE
6.4 ACCESSORIES
6.4.1 FILTERS
6.4.2 DETECTORS
6.4.3 OTHERS
6.5 SERVICES
6.6 SOFTWARE
7 EUROPE FLOW CYTOMETRY MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 CELL-BASED FLOW CYTOMETRY
7.3 BEAD-BASED FLOW CYTOMETRY
8 EUROPE FLOW CYTOMETRY MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 RESEARCH APPLICATIONS
8.2.1 CELL CYCLE ANALYSIS
8.2.2 CELL SORTING/SCREENING
8.2.3 CELL TRANSFECTION/VIABILITY
8.2.4 PHARMACEUTICAL AND BIOTECHNOLOGY
8.2.4.1 DRUG DISCOVERY
8.2.4.2 STEM CELL RESEARCH
8.2.4.3 IN VITRO TOXICITY TESTING
8.2.5 IMMUNOLOGY
8.2.6 APOPTOSIS
8.2.7 CELL COUNTING
8.2.8 OTHERS
8.3 CLINICAL APPLICATIONS
8.3.1 HAEMATOLOGY
8.3.2 CANCER
8.3.3 IMMUNODEFICIENCY DISEASES
8.3.4 ORGAN TRANSPLANTATION
8.3.5 OTHER CLINICAL APPLICATION
8.4 INDUSTRIAL APPLICATIONS
9 EUROPE FLOW CYTOMETRY MARKET, BY END USER
9.1 OVERVIEW
9.2 PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES
9.3 ACADEMIC & RESEARCH INSTITUTES
9.4 HOSPITALS
9.5 CLINICAL TESTING LABORATORIES
9.6 BLOOD BANK
9.7 OTHERS
10 EUROPE FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 RETAIL SALES
10.3 DIRECT TENDERS
11 EUROPE FLOW CYTOMETRY MARKET, BY GEOGRAPHY
11.1 EUROPE
11.1.1 GERMANY
11.1.2 FRANCE
11.1.3 U.K.
11.1.4 ITALY
11.1.5 SPAIN
11.1.6 RUSSIA
11.1.7 NETHERLANDS
11.1.8 SWITZERLAND
11.1.9 TURKEY
11.1.10 BELGIUM
11.1.11 REST OF EUROPE
12 EUROPE FLOW CYTOMETRY MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: EUROPE
13 SWOT ANALYSIS
14 COMPANY PROFILE
14.1 THERMO FISHER SCIENTIFIC INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 BD
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENT
14.2.5.1 COLLABORATION
14.3 AGILENT TECHNOLOGIES, INC.
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 SARTORIUS AG
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENT
14.5 NEXCELOM BIOSCIENCE LLC
14.5.1 COMPANY SNAPSHOT
14.5.2 PRODUCT PORTFOLIO
14.5.3 RECENT DEVELOPMENT
14.5.4 COMPANY SHARE ANALYSIS
14.6 APOGEE FLOW SYSTEMS LTD.
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENT
14.7 BAY BIOSCIENCE CO., LTD.
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENT
14.8 BIOMÉRIEUX
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENT
14.9 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER CORPORATION)
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT DEVELOPMENTS
14.9.4.1 ACQUISITION
14.9.4.2 PRODUCT LAUNCH
14.1 BENNUBIO INC.
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENT
14.11 BIOLEGEND, INC.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.12 BIO-RAD LABORATORIES, INC.
14.12.1 COMPANY SNAPSHOT
14.12.2 REVENUE ANALYSIS
14.12.3 PRODUCT PORTFOLIO
14.12.4 RECENT DEVELOPMENT
14.13 CELL SIGNALING TECHNOLOGY, INC.
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 CELLKRAFT BIOTECH PVT. LTD
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 CYTEK BIOSCIENCES
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENTS
14.15.3.1 PRODUCT LAUNCH
14.15.3.2 ACQUISITION
14.16 CYTOBUOY B.V.
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENT
14.17 CYTONOME/ST, LLC
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.18 COHERENT CORP.
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENTS
14.18.4.1 Announcement
14.18.4.2 PRODUCT LAUNCH
14.18.4.3 AWARDS
14.18.5 RECENT DEVELOPMENT
14.19 ELABSCIENCE BIOTECHNOLOGY INC.
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENT
14.2 ENZO BIOCHEM INC.
14.20.1 COMPANY SNAPSHOT
14.20.2 REVENUE ANALYSIS
14.20.3 PRODUCT PORTFOLIO
14.20.4 RECENT DEVELOPMENT
14.21 IKEDA SCIENTIFIC CO., LTD.
14.21.1 COMPANY SNAPSHOT
14.21.2 PRODUCT PORTFOLIO
14.21.3 RECENT DEVELOPMENT
14.22 MERCK KGAA
14.22.1 COMPANY SNAPSHOT
14.22.2 REVENUE ANALYSIS
14.22.3 PRODUCT PORTFOLIO
14.22.4 RECENT DEVELOPMENT
14.23 MILTENYI BIOTEC
14.23.1 COMPANY SNAPSHOT
14.23.2 PRODUCT PORTFOLIO
14.23.3 RECENT DEVELOPMENT
14.23.3.1 PRODUCT LAUNCH
14.24 NANOCELLECT BIOMEDICAL
14.24.1 COMPANY SNAPSHOT
14.24.2 PRODUCT PORTFOLIO
14.24.3 RECENT DEVELOPMENTS
14.25 NEOGENOMICS LABORATORIES
14.25.1 COMPANY SNAPSHOT
14.25.2 REVENUE ANALYSIS
14.25.3 PRODUCT PORTFOLIO
14.25.4 RECENT DEVELOPMENT
14.26 ON-CHIP BIOTECHNOLOGIES CO., LTD. CORPORATION
14.26.1 COMPANY SNAPSHOT
14.26.2 PRODUCT PORTFOLIO
14.26.3 RECENT DEVELOPMENTS
14.27 ORFLO TECHNOLOGIES
14.27.1 COMPANY SNAPSHOT
14.27.2 PRODUCT PORTFOLIO
14.27.3 RECENT DEVELOPMENT
14.28 Q2 SOLUTION
14.28.1 COMPANY SNAPSHOT
14.28.2 REVENUE ANALYSIS
14.28.3 SERVICE PORTFOLIO
14.28.4 RECENT DEVELOPMENT
14.29 SONY BIOTECHNOLOGY INC.
14.29.1 COMPANY SNAPSHOT
14.29.2 PRODUCT PORTFOLIO
14.29.3 RECENT DEVELOPMENT
14.3 STRATEDIGM, INC
14.30.1 COMPANY SNAPSHOT
14.30.2 PRODUCT PORTFOLIO
14.30.3 RECENT DEVELOPMENT
14.31 SYSMEX CORPORATION
14.31.1 COMPANY SNAPSHOT
14.31.2 REVENUE ANALYSIS
14.31.3 PRODUCT PORTFOLIO
14.31.4 RECENT DEVELOPMENT
14.32 TAKARA BIO INC.
14.32.1 COMPANY SNAPSHOT
14.32.2 REVENUE ANALYSIS
14.32.3 PRODUCT PORTFOLIO
14.32.4 RECENT DEVELOPMENTS
14.33 UNION BIOMETRICA, INC.
14.33.1 COMPANY SNAPSHOT
14.33.2 PRODUCT PORTFOLIO
14.33.3 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
표 목록
TABLE 1 EUROPE FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 2 EUROPE REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 EUROPE REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 4 EUROPE FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 EUROPE FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 6 EUROPE CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 7 EUROPE CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 8 EUROPE CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 9 EUROPE ACCESSORIES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 EUROPE ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 11 EUROPE SERVICES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 EUROPE SOFTWARE IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 EUROPE FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 14 EUROPE CELL-BASED FLOW CYTOMETRY IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 EUROPE BEAD-BASED FLOW CYTOMETRY IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 EUROPE FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 17 EUROPE RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 EUROPE RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 19 EUROPE PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 20 EUROPE CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 EUROPE CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 22 EUROPE INDUSTRIAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 EUROPE FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 24 EUROPE PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 EUROPE ACADEMIC & RESEARCH INSTITUTES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 EUROPE HOSPITALS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 EUROPE CLINICAL TESTING LABORATORIES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 28 EUROPE BLOOD BANK IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 EUROPE OTHERS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 EUROPE FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 31 EUROPE RETAIL SALES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 EUROPE DIRECT TENDERS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 EUROPE FLOW CYTOMETRY MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 34 EUROPE FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 35 EUROPE REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 36 EUROPE FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 37 EUROPE CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 38 EUROPE CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 39 EUROPE CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 40 EUROPE ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 41 EUROPE FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 42 EUROPE FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 43 EUROPE RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 44 EUROPE PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 45 EUROPE CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 46 EUROPE FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 47 EUROPE FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 48 GERMANY FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 49 GERMANY REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 50 GERMANY FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 51 GERMANY CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 52 GERMANY CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 53 GERMANY CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 54 GERMANY ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 55 GERMANY FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 56 GERMANY FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 57 GERMANY RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 58 GERMANY PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 59 GERMANY CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 60 GERMANY FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 61 GERMANY FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 62 FRANCE FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 63 FRANCE REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 64 FRANCE FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 65 FRANCE CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 66 FRANCE CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 67 FRANCE CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 68 FRANCE ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 69 FRANCE FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 70 FRANCE FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 71 FRANCE RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 72 FRANCE PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 73 FRANCE CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 74 FRANCE FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 75 FRANCE FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 76 U.K. FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 77 U.K. REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 78 U.K. FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 79 U.K. CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 80 U.K. CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 81 U.K. CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 82 U.K. ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 83 U.K. FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 84 U.K. FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 85 U.K. RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 86 U.K. PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 87 U.K. CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 88 U.K. FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 89 U.K. FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 90 ITALY FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 91 ITALY REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 92 ITALY FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 93 ITALY CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 94 ITALY CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 95 ITALY CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 96 ITALY ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 97 ITALY FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 98 ITALY FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 99 ITALY RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 100 ITALY PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 101 ITALY CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 102 ITALY FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 103 ITALY FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 104 SPAIN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 105 SPAIN REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 106 SPAIN FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 107 SPAIN CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 108 SPAIN CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 109 SPAIN CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 110 SPAIN ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 111 SPAIN FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 112 SPAIN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 113 SPAIN RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 114 SPAIN PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 115 SPAIN CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 116 SPAIN FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 117 SPAIN FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 118 RUSSIA FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 119 RUSSIA REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 120 RUSSIA FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 121 RUSSIA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 122 RUSSIA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 123 RUSSIA CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 124 RUSSIA ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 125 RUSSIA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 126 RUSSIA FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 127 RUSSIA RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 128 RUSSIA PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 129 RUSSIA CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 130 RUSSIA FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 131 RUSSIA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 132 NETHERLANDS FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 133 NETHERLANDS REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 134 NETHERLANDS FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 135 NETHERLANDS CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 136 NETHERLANDS CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 137 NETHERLANDS CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 138 NETHERLANDS ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 139 NETHERLANDS FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 140 NETHERLANDS FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 141 NETHERLANDS RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 142 NETHERLANDS PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 143 NETHERLANDS CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 144 NETHERLANDS FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 145 NETHERLANDS FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 146 SWITZERLAND FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 147 SWITZERLAND REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 148 SWITZERLAND FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 149 SWITZERLAND CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 150 SWITZERLAND CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 151 SWITZERLAND CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 152 SWITZERLAND ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 153 SWITZERLAND FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 154 SWITZERLAND FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 155 SWITZERLAND RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 156 SWITZERLAND PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 157 SWITZERLAND CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 158 SWITZERLAND FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 159 SWITZERLAND FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 160 TURKEY FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 161 TURKEY REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 162 TURKEY FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 163 TURKEY CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 164 TURKEY CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 165 TURKEY CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 166 TURKEY ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 167 TURKEY FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 168 TURKEY FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 169 TURKEY RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 170 TURKEY PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 171 TURKEY CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 172 TURKEY FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 173 TURKEY FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 174 BELGIUM FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 175 BELGIUM REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 176 BELGIUM FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 177 BELGIUM CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 178 BELGIUM CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 179 BELGIUM CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 180 BELGIUM ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 181 BELGIUM FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 182 BELGIUM FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 183 BELGIUM RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 184 BELGIUM PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 185 BELGIUM CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 186 BELGIUM FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 187 BELGIUM FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 188 REST OF EUROPE FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
그림 목록
FIGURE 1 EUROPE FLOW CYTOMETRY MARKET: SEGMENTATION
FIGURE 2 EUROPE FLOW CYTOMETRY MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE FLOW CYTOMETRY MARKET: DROC ANALYSIS
FIGURE 4 EUROPE FLOW CYTOMETRY MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 EUROPE FLOW CYTOMETRY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE FLOW CYTOMETRY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE FLOW CYTOMETRY MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE FLOW CYTOMETRY MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 EUROPE FLOW CYTOMETRY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE FLOW CYTOMETRY MARKET: SEGMENTATION
FIGURE 11 INCREASING INCIDENCE AND PREVALENCE OF CHRONIC DISEASES ARE EXPECTED TO DRIVE THE EUROPE FLOW CYTOMETRY MARKET IN THE FORECAST PERIOD
FIGURE 12 THE REAGENTS AND CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE FLOW CYTOMETRY MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE FLOW CYTOMETRY MARKET
FIGURE 14 EUROPE FLOW CYTOMETRY MARKET: BY PRODUCT, 2022
FIGURE 15 EUROPE FLOW CYTOMETRY MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 16 EUROPE FLOW CYTOMETRY MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 EUROPE FLOW CYTOMETRY MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 EUROPE FLOW CYTOMETRY MARKET: BY TECHNOLOGY, 2022
FIGURE 19 EUROPE FLOW CYTOMETRY MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION)
FIGURE 20 EUROPE FLOW CYTOMETRY MARKET: BY TECHNOLOGY, CAGR (2023-2030)
FIGURE 21 EUROPE FLOW CYTOMETRY MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 22 EUROPE FLOW CYTOMETRY MARKET: BY APPLICATION, 2022
FIGURE 23 EUROPE FLOW CYTOMETRY MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 24 EUROPE FLOW CYTOMETRY MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 EUROPE FLOW CYTOMETRY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 EUROPE FLOW CYTOMETRY MARKET: BY END USER, 2022
FIGURE 27 EUROPE FLOW CYTOMETRY MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 EUROPE FLOW CYTOMETRY MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 EUROPE FLOW CYTOMETRY MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 EUROPE FLOW CYTOMETRY MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 EUROPE FLOW CYTOMETRY MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 EUROPE FLOW CYTOMETRY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 EUROPE FLOW CYTOMETRY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 EUROPE FLOW CYTOMETRY MARKET: SNAPSHOT (2022)
FIGURE 35 EUROPE FLOW CYTOMETRY MARKET: BY COUNTRY (2022)
FIGURE 36 EUROPE FLOW CYTOMETRY MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 EUROPE FLOW CYTOMETRY MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 EUROPE FLOW CYTOMETRY MARKET: PRODUCT (2023-2030)
FIGURE 39 EUROPE FLOW CYTOMETRY MARKET: COMPANY SHARE 2022 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
